277
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Role of Treatment Adherence, Doctor–Patient Trust, and Communication in Predicting Treatment Effects Among Tuberculosis Patients: Difference Between Urban and Rural Areas

ORCID Icon, ORCID Icon, , , &
Pages 2327-2336 | Published online: 24 Nov 2020

References

  • World Health Organization. Global Tuberculosis Report 2019. WHO/CDS/TB/2019.15. Geneva, Switzerland: World Health Organization;2019.
  • Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990–2010; a longitudinal analysis of national survey data. Lancet. 2014;383(9934):2057–2064. doi:10.1016/S0140-6736(13)62639-2
  • Xu CH, Jeyashree K, Shewade HD, et al. Inequity in catastrophic costs among tuberculosis-affected households in China. Infect Dis Poverty. 2019;8(1):46. doi:10.1186/s40249-019-0564-2
  • Wang Y, Li Y, Qin S, et al. The disequilibrium in the distribution of the primary health workforce among eight economic regions and between rural and urban areas in China. Int J Equity Health. 2020;19(1):28. doi:10.1186/s12939-020-1139-3
  • Zha BS, Nahid P. Treatment of drug-susceptible tuberculosis. Clin Chest Med. 2019;40(4):763–774. doi:10.1016/j.ccm.2019.07.006
  • Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):1230–1245. doi:10.1371/journal.pmed.0040238
  • Tweed CD, Dawson R, Burger DA, et al. Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. Lancet Respir Med. 2019;7(12):1048–1058. doi:10.1016/S2213-2600(19)30366-2
  • Keutzer L, Wicha SG, Simonsson US. Mobile health apps for improvement of tuberculosis treatment: descriptive review. JMIR Mhealth Uhealth. 2020;8(4):e17246. doi:10.2196/17246
  • Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Systematic Rev. 2008;(2):129.
  • Sotgiu G, Centis R, D’Ambrosio L, Migliori GB. Tuberculosis treatment and drug regimens. Cold Spring Harb Perspect Med. 2015;5(5):a017822. doi:10.1101/cshperspect.a017822
  • Zhang J, Yang Y, Qiao X, et al. Factors influencing medication nonadherence to pulmonary tuberculosis treatment in tibet, china: a qualitative study from the patient perspective. Patient Prefer Adherence. 2020;14:1149–1158. doi:10.2147/PPA.S252448
  • Petrocchi S, Iannello P, Lecciso F, Levante A, Antonietti A, Schulz PJ. Interpersonal trust in doctor-patient relation: evidence from dyadic analysis and association with quality of dyadic communication. Soc Sci Med. 2019;235:8. doi:10.1016/j.socscimed.2019.112391
  • Bredart A, Bouleuc C, Dolbeault S. Doctor-patient communication and satisfaction with care in oncology. Curr Opin Oncol. 2005;17(4):351–354. doi:10.1097/01.cco.0000167734.26454.30
  • Shan W, Wang Y, Luan J, Tang P. The Influence of physician information on patients’ choice of physician in mHealth services using China’s chunyu doctor app: eye-tracking and questionnaire study. JMIR Mhealth Uhealth. 2019;7(10):e15544. doi:10.2196/15544
  • Xu ML, Markstrom U, Lyu JC, Xu LZ. Detection of low adherence in rural tuberculosis patients in china: application of morisky medication adherence scale. Int J Environ Res Public Health. 2017;14(3):10.
  • Du L, Chen X, Zhu X, et al. Determinants of medication adherence for pulmonary tuberculosis patients during continuation phase in dalian, Northeast China. Patient Prefer Adherence. 2020;14:1119–1128. doi:10.2147/PPA.S243734
  • Kao AC, Green DC, Zaslavsky AM, Koplan JP, Cleary PD. The relationship between method of physician payment and patient trust. JAMA. 1998;280(19):1708–1714. doi:10.1001/jama.280.19.1708
  • Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma. Ophthalmology. 2008;115(8):1320–1327. doi:10.1016/j.ophtha.2007.11.023
  • Ren J, Li Q, Zhang T, et al. Perceptions of engagement in health care among patients with tuberculosis: a qualitative study. Patient Prefer Adherence. 2019;13:107–117. doi:10.2147/PPA.S191800
  • Tupasi T, Garfin A, Mangan JM, et al. Multidrug-resistant tuberculosis patients’ views of interventions to reduce treatment loss to follow-up. Int J Tuberculosis Lung Disease. 2017;21(1):23–31. doi:10.5588/ijtld.16.0433
  • Adams LV, Basu D, Grande SW, et al. Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study. Int J Tuberculosis Lung Disease. 2017;21(5):571–578. doi:10.5588/ijtld.16.0669
  • Ayele AA, Asrade Atnafie S, Balcha DD, et al. Self-reported adherence and associated factors to isoniazid preventive therapy for latent tuberculosis among people living with HIV/AIDS at health centers in Gondar town, North West Ethiopia. Patient Prefer Adherence. 2017;11:743–749. doi:10.2147/PPA.S131314
  • Steihaug S, Gulbrandsen P, Werner A. Recognition can leave room for disagreement in the doctor-patient consultation. Patient Educ Couns. 2012;86(3):316–321. doi:10.1016/j.pec.2011.06.011
  • Long Q, Qu Y, Lucas H. Drug-resistant tuberculosis control in China: progress and challenges. Infect Dis Poverty. 2016;5:9.
  • Ai X, Men K, Guo L, et al. Factors associated with low cure rate of tuberculosis in remote poor areas of Shaanxi Province, China: a case control study. BMC Public Health. 2010;10:112. doi:10.1186/1471-2458-10-112
  • Chen S, Zhang H, Pan Y, et al. Are free anti-tuberculosis drugs enough? An empirical study from three cities in China. Infect Dis Poverty. 2015;4:47. doi:10.1186/s40249-015-0080-y
  • Hall MA, Zheng B, Dugan E, et al. Measuring patients’ trust in their primary care providers. Medical Care Research Review. 2002;59(3):293–318. doi:10.1177/1077558702059003004
  • Hays RD, Chawla N, Kent EE, Arora NK. Measurement equivalence of the Consumer Assessment of Healthcare Providers and Systems (CAHPS((R))) Medicare survey items between Whites and Asians. Quality Life Res. 2017;26(2):311–318. doi:10.1007/s11136-016-1383-6
  • Brown J, Capocci S, Smith C, Morris S, Abubakar I, Lipman M. Health status and quality of life in tuberculosis. Int J Infect Dis. 2015;32:68–75. doi:10.1016/j.ijid.2014.12.045
  • Hayes AF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. The Guilford Press; 2018.
  • Hayes AF, Baron B, Kenny. Statistical mediation analysis in the new millennium. Commun Monogr. 2009;4:408–420. doi:10.1080/03637750903310360
  • Wu S, Roychowdhury I, Khan M. Evaluating the impact of healthcare provider training to improve tuberculosis management: a systematic review of methods and outcome indicators used. Int J Infect Dis. 2017;56:105–110. doi:10.1016/j.ijid.2016.11.421
  • Valencia S, León M, Losada I, Sequera VG, Fernández QM, García-Basteiro AL. How do we measure adherence to anti-tuberculosis treatment? Expert Rev Anti Infect Ther. 2017;15(2):157–165. doi:10.1080/14787210.2017.1264270
  • Sariem CN, Odumosu P, Dapar MP, Musa J, Ibrahim L, Aguiyi J. Tuberculosis treatment outcomes: a fifteen-year retrospective study in Jos-North and Mangu, Plateau State, North - Central Nigeria. BMC Public Health. 2020;20(1):1224. doi:10.1186/s12889-020-09289-x
  • Alipanah N, Jarlsberg L, Miller C, et al. Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595.
  • Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database Syst Rev. 2015;2015(9):Cd007952.
  • Wang X, Wu Z. Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China. Aids. 2007;21(Suppl 8):S149–155. doi:10.1097/01.aids.0000304711.87164.99
  • Li Y, Ehiri J, Tang S, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156. doi:10.1186/1741-7015-11-156
  • Yuan L, Zhang H, Zhou C, Jiang W, Zhao Q, Biao X. Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China. BMC Infect Dis. 2017;17(1):71. doi:10.1186/s12879-016-2108-8
  • Wang Q, Kong YJ, Sun JY, Zhang Y, Yuan LL, Wang J. What are the challenges faced by village doctors in provision of basic public health services in shandong, china? A qualitative study. Int J Environ Res Public Health. 2019;16(14):18.
  • Roettl J, Bidmon S, Terlutter R. What predicts patients’ willingness to undergo online treatment and pay for online treatment? Results from a web-based survey to investigate the changing patient-physician relationship. J Med Internet Res. 2016;18(2):15. doi:10.2196/jmir.5244
  • Maatouk-Burmann B, Ringel N, Spang J, et al. Improving patient-centered communication: results of a randomized controlled trial. Patient Educ Couns. 2016;99(1):117–124. doi:10.1016/j.pec.2015.08.012
  • Dang BN, Westbrook RA, Njue SM, Giordano TP. Building trust and rapport early in the new doctor-patient relationship: a longitudinal qualitative study. BMC Med Educ. 2017;17:10. doi:10.1186/s12909-017-0868-5